drugset / Trial / NCT07192263
Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This Phase 3 study is designed to evaluate the efficacy and safety of IN-B00009 injection in adults with obesity or overweight without diabetes mellitus
Timeline
- Start
- 2025-09-22
- Primary completion
- 2026-12-31
- Completion
- 2027-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IN-B00009 | Unknown | — | — |